These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29676232)

  • 1. Pharmacoepigenetics and Pharmacoepigenomics: An Overview.
    Peedicayil J
    Curr Drug Discov Technol; 2019; 16(4):392-399. PubMed ID: 29676232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoepigenetics: an element of personalized therapy?
    Majchrzak-Celińska A; Baer-Dubowska W
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):387-398. PubMed ID: 27860490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy.
    Griñán-Ferré C; Bellver-Sanchis A; Guerrero A; Pallàs M
    Pharmacol Res; 2024 Jul; 205():107247. PubMed ID: 38834164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers.
    Lopomo A; Coppedè F
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):49-62. PubMed ID: 28856927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmocoepigenetics: a new approach to predicting individual drug responses and targeting new drugs.
    Baer-Dubowska W; Majchrzak-Celińska A; Cichocki M
    Pharmacol Rep; 2011; 63(2):293-304. PubMed ID: 21602587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenomics, Pharmacoepigenomics, and Personalized Medicine in Cervical Cancer.
    Kabekkodu SP; Chakrabarty S; Ghosh S; Brand A; Satyamoorthy K
    Public Health Genomics; 2017; 20(2):100-115. PubMed ID: 28521327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promises and challenges in pharmacoepigenetics.
    Smith DA; Sadler MC; Altman RB
    Camb Prism Precis Med; 2023; 1():e18. PubMed ID: 37560024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenomics and interindividual differences in drug response.
    Ivanov M; Kacevska M; Ingelman-Sundberg M
    Clin Pharmacol Ther; 2012 Dec; 92(6):727-36. PubMed ID: 23093317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoepigenomics: a key determinant in resolving epigenomic parameters in pathogenesis and treatment response in complex diseases.
    Banerjee M
    Pharmacogenomics; 2022 Jan; 23(2):81-84. PubMed ID: 34842441
    [No Abstract]   [Full Text] [Related]  

  • 10. Moving pharmacoepigenetics tools for depression toward clinical use.
    Hack LM; Fries GR; Eyre HA; Bousman CA; Singh AB; Quevedo J; John VP; Baune BT; Dunlop BW
    J Affect Disord; 2019 Apr; 249():336-346. PubMed ID: 30802699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoepigenetics and pharmacoepigenomics.
    Peedicayil J
    Pharmacogenomics; 2008 Dec; 9(12):1785-6. PubMed ID: 19072635
    [No Abstract]   [Full Text] [Related]  

  • 12. Overlapping effects of genetic variation and epigenetics on drug response: challenges of pharmacoepigenomics.
    Cascorbi I
    Pharmacogenomics; 2013 Nov; 14(15):1807-9. PubMed ID: 24236479
    [No Abstract]   [Full Text] [Related]  

  • 13. Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug Response.
    Cacabelos R; Torrellas C
    Int J Mol Sci; 2015 Dec; 16(12):30483-543. PubMed ID: 26703582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoepigenetics in type 2 diabetes: is it clinically relevant?
    Ling C
    Diabetologia; 2022 Nov; 65(11):1849-1853. PubMed ID: 35307762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics primer: why the clinician should care about epigenetics.
    Duarte JD
    Pharmacotherapy; 2013 Dec; 33(12):1362-8. PubMed ID: 23864439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics and pharmacoepigenomics in pediatric medicine.
    Shastry BS
    Methods Mol Biol; 2014; 1175():671-85. PubMed ID: 25150880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics in the treatment of systemic lupus erythematosus: potential clinical application.
    Guo Y; Sawalha AH; Lu Q
    Clin Immunol; 2014 Nov; 155(1):79-90. PubMed ID: 25218424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.
    Yu AM; Tian Y; Tu MJ; Ho PY; Jilek JL
    Drug Metab Dispos; 2016 Mar; 44(3):308-19. PubMed ID: 26566807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic changes in gene expression for drug-metabolizing enzymes and transporters.
    Kim IW; Han N; Burckart GJ; Oh JM
    Pharmacotherapy; 2014 Feb; 34(2):140-50. PubMed ID: 24166985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic mechanisms of importance for drug treatment.
    Ivanov M; Barragan I; Ingelman-Sundberg M
    Trends Pharmacol Sci; 2014 Aug; 35(8):384-96. PubMed ID: 24993164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.